# GNOLF (Genoil Inc.) - SEC EDGAR Financial Statements

> Genoil Inc. reported $0 in revenue and a net loss of $2.09M for the fiscal year ended December 31, 2024.

- Canonical: https://convexityos.com/fundamentals/GNOLF
- Markdown: https://convexityos.com/fundamentals/GNOLF.md
- SEC CIK: 0001261002
- Reporting currency: USD
- Latest filing period: December 31, 2024
- Last synced: Nov 21, 2026, 05:00 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001261002&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2024 | $0 | Dec 31, 2024 |
| Operating Income | FY 2024 | -$2.01M | Operating profit |
| Net Income | FY 2024 | -$2.09M | GAAP bottom line |
| Diluted EPS | FY 2024 | -- | Split-adjusted |
| Free Cash Flow | FY 2024 | -- | Operating CF less CapEx |
| Cash & ST Investments | Dec 31, 2024 | -- | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $0 | $0 | $0 |
| Cost of Revenue | $0 | $0 | -- | -- | -- |
| **Gross Profit** | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $2.01M | $3.66M | $1.65M | $1.07M | $3.82M |
| **Operating Income** | -$2.01M | -$3.66M | -$1.65M | -$1.07M | -$3.82M |
| Interest Expense | -- | -- | $1.93M | $1.35M | $719K |
| Income Before Tax | -$2.09M | -$4.33M | -$3.58M | -$2.42M | -$4.54M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$2.09M | -$4.33M | -$3.58M | -$2.42M | -$4.54M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | -- | -- | $5.0K | $12 | $3.4K |
| **Cash & Short-Term Investments** | -- | -- | $5.0K | $12 | $3.4K |
| **Total Current Assets** | $96K | $95K | $283K | $229K | $156K |
| Intangible Assets | -- | -- | $1 | $1 | $1 |
| **Total Non-Current Assets** | $37K | $145K | $43K | $43K | $43K |
| **Total Assets** | $134K | $241K | $326K | $272K | $199K |
| **Total Current Liabilities** | $244K | $168K | $11.12M | $9.19M | $3.10M |
| **Total Non-Current Liabilities** | $214K | $208K | $0 | $0 | $4.71M |
| **Total Liabilities** | $458K | $376K | $11.12M | $9.19M | $7.81M |
| Common Stock | $64.20M | $63.64M | $51.47M | $50.92M | $50.46M |
| Retained Earnings | -$105.9M | -$103.8M | -$99.34M | -$95.76M | -$93.26M |
| Accumulated Other Comp. Income | -$222K | -$222K | -$222K | -$222K | -$222K |
| **Total Stockholders' Equity** | -$325K | -$135K | -$10.96M | -$8.91M | -$7.61M |
| Total Equity | -$325K | -$135K | -$10.96M | -$8.91M | -$7.61M |

### Balance Sheet (Quarterly)

| Line Item | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
| --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | -- | -- | $5.0K | $12 | $3.4K |
| **Cash & Short-Term Investments** | -- | -- | $5.0K | $12 | $3.4K |
| **Total Current Assets** | $96K | $95K | $283K | $229K | $156K |
| Intangible Assets | -- | -- | $1 | $1 | $1 |
| **Total Non-Current Assets** | $37K | $145K | $43K | $43K | $43K |
| **Total Assets** | $134K | $241K | $326K | $272K | $199K |
| **Total Current Liabilities** | $244K | $168K | $11.12M | $9.19M | $3.10M |
| **Total Non-Current Liabilities** | $214K | $208K | $0 | $0 | $4.71M |
| **Total Liabilities** | $458K | $376K | $11.12M | $9.19M | $7.81M |
| Common Stock | $64.20M | $63.64M | $51.47M | $50.92M | $50.46M |
| Retained Earnings | -$105.9M | -$103.8M | -$99.34M | -$95.76M | -$93.26M |
| Accumulated Other Comp. Income | -$222K | -$222K | -$222K | -$222K | -$222K |
| **Total Stockholders' Equity** | -$325K | -$135K | -$10.96M | -$8.91M | -$7.61M |
| Total Equity | -$325K | -$135K | -$10.96M | -$8.91M | -$7.61M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- |
| Net Income | -$2.09M | -$4.33M | -$3.58M | -$2.51M | -$4.54M |
| Stock-Based Compensation | $1.35M | $3.10M | $1.24M | $717K | $3.48M |
| Change in Payables | $48K | -$4.8K | -- | -- | -- |
| **Operating Cash Flow** | -$606K | -$646K | -$398K | -$317K | -$330K |
| **Financing Cash Flow** | $608K | $651K | $403K | $314K | $332K |
| **Net Change in Cash** | $1.6K | $5.4K | $5.0K | -$3.4K | $2.0K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- |
| Return on Assets (ROA) | -1561.4% | -1797.2% | -1097.7% | -889.3% | -2279.0% |
| Current Ratio | 0.40x | 0.57x | 0.03x | 0.02x | 0.05x |
| Quick Ratio | -- | -- | 0.00x | 0.00x | 0.00x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
